Sesen Bio researches, discovers, develops and commercializes antibody-drug conjugate therapies for the treatment of cancer.
Business Model:
Revenue: $60M
Employees: 11-50
Address: 245 First Street
City: Cambridge
State: MA
Zip: 02142
Country: US
Sesen Bio researches, discovers, develops and commercializes antibody-drug conjugate therapies for the treatment of cancer.
Contact Phone:
+16174448550
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/7/2014
IPO Valuation:
$206M
Ticker Symbol:
SESN
IPO Price:
$10/share
Amount Raised:
$50M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2012 | Series A | 3 | $20M |
JAFCO Flagship Pioneering Third Rock Ventures JAFCO JAFCO Flagship Pioneering Third Rock Ventures JAFCO |
2/2014 | IPO | $50M | 3/2015 | Post-IPO Equity | 1 | $40M |
Cowen Group Cowen Group |
3/2018 | Equity | $996k | 9/2016 | Equity | $13.5M | 12/2014 | Equity | $20M |
Third Rock Ventures |
6/2018 | Post-IPO Equity | $40M | 11/2014 | Post-IPO Equity | $20M | 11/2017 | Post-IPO Equity | $8M | 3/2010 | Series A | 2 | $35M |
Flagship Pioneering Third Rock Ventures Flagship Pioneering Third Rock Ventures Flagship Pioneering Third Rock Ventures Flagship Pioneering Third Rock Ventures |
---|
Announced Date | Name | Price |
---|---|---|
9/2016 | Viventia Bio |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|